Baclofen (Kemstro®) | UCB
UCB's Global Corporate Website

Baclofen (Kemstro®)

Disease area studied Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available)
Multiple Sclerosis A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis Phase 3 SP0843
Completed
NCT00139789 PDFFFFF